{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:37:11Z","timestamp":1794854231533,"version":"4.9.1"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32200764"],"award-info":[{"award-number":["32200764"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32471004"],"award-info":[{"award-number":["32471004"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011933","name":"Chongqing Science and Technology Development Foundation","doi-asserted-by":"publisher","award":["CSTB 2024NSCQ- KJFZZDX0033"],"award-info":[{"award-number":["CSTB 2024NSCQ- KJFZZDX0033"]}],"id":[{"id":"10.13039\/501100011933","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020789","name":"Shuangchuang Program of Jiangsu Province","doi-asserted-by":"publisher","award":["2024"],"award-info":[{"award-number":["2024"]}],"id":[{"id":"10.13039\/501100020789","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012154","name":"Graduate Research and Innovation Projects of Jiangsu Province","doi-asserted-by":"publisher","award":["KYCX23-0866"],"award-info":[{"award-number":["KYCX23-0866"]}],"id":[{"id":"10.13039\/501100012154","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002857","name":"China Pharmaceutical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002857","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jconrel.2025.114218","type":"journal-article","created":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T17:40:22Z","timestamp":1757439622000},"page":"114218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Novel TNF-\u03b1-targeting mRNA therapy for sustained psoriasis treatment and relapse prevention by suppressing IL-15-TRM signaling"],"prefix":"10.1016","volume":"387","author":[{"given":"Xi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianyu","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangzheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Qiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.114218_bb0005","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jaci.2019.09.025","article-title":"Targeting L-type amino acid transporter 1 in innate and adaptive T cells efficiently controls skin inflammation","volume":"145","author":"Cibrian","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2025.114218_bb0010","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1172\/JCI93396","article-title":"Clinically resolved psoriatic lesions contain psoriasis-specific IL-17-producing \u03b1\u03b2 T cell clones","volume":"127","author":"Matos","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2025.114218_bb0015","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2025.114218_bb0020","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s00403-024-02846-z","article-title":"Global burden and future trends in psoriasis epidemiology: insights from the global burden of disease study 2019 and predictions to 2030","volume":"316","author":"Wang","year":"2024","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.jconrel.2025.114218_bb0025","article-title":"Global burden and cross-country inequalities in autoimmune diseases from 1990 to 2019","volume":"22","author":"Cao","year":"2023","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jconrel.2025.114218_bb0030","doi-asserted-by":"crossref","unstructured":"G. Damiani, N.L. Bragazzi, C. Karimkhani Aksut, et al., the global, regional, and national burden of psoriasis: results and insights from the global burden of disease 2019 study, Front Med (Lausanne), 8 (2021) 743180. DOI: https:\/\/doi.org\/10.3389\/fmed.2021.743180.","DOI":"10.3389\/fmed.2021.743180"},{"key":"10.1016\/j.jconrel.2025.114218_bb0035","doi-asserted-by":"crossref","DOI":"10.2340\/actadv.v105.42945","article-title":"Epidemiology of psoriasis: a worldwide global study","volume":"105","author":"Skayem","year":"2025","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.jconrel.2025.114218_bb0040","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1111\/1346-8138.16941","article-title":"Association of psoriasis with depression, anxiety, and suicidality: a bidirectional two-sample Mendelian randomization study","volume":"50","author":"Chu","year":"2023","journal-title":"J. Dermatol."},{"key":"10.1016\/j.jconrel.2025.114218_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.652191","article-title":"Resident memory T cells in autoimmune skin diseases","volume":"12","author":"Ryan","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.114218_bb0050","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41577-021-00590-3","article-title":"The precursors of CD8(+) tissue resident memory T cells: from lymphoid organs to infected tissues","volume":"22","author":"Kok","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.114218_bb0055","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.83981","article-title":"CD8(+) tissue-resident memory T cells induce oral lichen planus erosion via cytokine network","volume":"12","author":"Qing","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.jconrel.2025.114218_bb0060","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1172\/JCI118321","article-title":"Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro","volume":"96","author":"Carson","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2025.114218_bb0065","doi-asserted-by":"crossref","first-page":"735","DOI":"10.4049\/jimmunol.156.2.735","article-title":"Induction and regulation of IL-15 expression in murine macrophages","volume":"156","author":"Doherty","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2025.114218_bb0070","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.4049\/jimmunol.158.6.2610","article-title":"Induction of IL-15 messenger RNA and protein in human blood-derived dendritic cells: a role for IL-15 in attraction of T cells","volume":"158","author":"Jonuleit","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2025.114218_bb0075","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/1523-1747.ep12338641","article-title":"Interleukin-15 mRNA is expressed by human keratinocytes Langerhans cells, and blood-derived dendritic cells and is downregulated by ultraviolet B radiation","volume":"106","author":"Blauvelt","year":"1996","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jconrel.2025.114218_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069356","article-title":"TNF stimulates nuclear export and secretion of IL-15 by acting on CRM1 and ARF6","volume":"8","author":"Ouyang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2025.114218_bb0085","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/35636","article-title":"Requirement for IRF-1 in the microenvironment supporting development of natural killer cells","volume":"391","author":"Ogasawara","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.114218_bb0090","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1084\/jem.187.6.967","article-title":"The transcription factor interferon regulatory factor 1 (IRF-1) is important during the maturation of natural killer 1.1+ T cell receptor-alpha\/beta+ (NK1+ T) cells, natural killer cells, and intestinal intraepithelial T cells","volume":"187","author":"Ohteki","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2025.114218_bb0095","doi-asserted-by":"crossref","first-page":"6724","DOI":"10.1038\/sj.onc.1210757","article-title":"Hematopoietic cytokine receptor signaling","volume":"26","author":"Baker","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.jconrel.2025.114218_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002510050393","article-title":"The NF-kappaB binding site is essential for transcriptional activation of the IL-15 gene","volume":"48","author":"Washizu","year":"1998","journal-title":"Immunogenetics"},{"key":"10.1016\/j.jconrel.2025.114218_bb0105","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1073\/pnas.95.5.2452","article-title":"Human T cell lymphotropic virus type I tax protein trans-activates interleukin 15 gene transcription through an NF-kappaB site","volume":"95","author":"Azimi","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2025.114218_bb0110","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1111\/jdv.16915","article-title":"EuroGuiDerm guideline on the systemic treatment of psoriasis vulgaris - part 1: treatment and monitoring recommendations","volume":"34","author":"Nast","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.jconrel.2025.114218_bb0115","article-title":"Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis","volume":"5","author":"Sbidian","year":"2022","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jconrel.2025.114218_bb0120","article-title":"Challenges and future trends in the treatment of psoriasis","volume":"24","author":"Lee","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2025.114218_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23158575","article-title":"Vitamin D signaling in psoriasis: pathogenesis and therapy","volume":"23","author":"Bro\u017cyna","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2025.114218_bb0130","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s40257-022-00679-y","article-title":"Time to relapse after discontinuing systemic treatment for psoriasis: a systematic review","volume":"23","author":"Masson Regnault","year":"2022","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.jconrel.2025.114218_bb0135","doi-asserted-by":"crossref","unstructured":"C.H. Smith, Z.Z.N. Yiu, T. Bale, et al., British Association of Dermatologists guidelines for biologic therapy for psoriasis 2020: a rapid update, Br. J. Dermatol., 183 (2020) 628\u2013637. DOI: https:\/\/doi.org\/10.1111\/bjd.19039.","DOI":"10.1111\/bjd.19039"},{"key":"10.1016\/j.jconrel.2025.114218_bb0140","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1080\/1744666X.2020.1771182","article-title":"TNF-\u03b1 inhibitors biosimilars as first line systemic treatment for moderate-to-severe chronic plaque psoriasis","volume":"16","author":"Gisondi","year":"2020","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.jconrel.2025.114218_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2024.103530","article-title":"Formation and clinical effects of anti-drug antibodies against biologics in psoriasis treatment: an analysis of current evidence","volume":"23","author":"Sun","year":"2024","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jconrel.2025.114218_bb0150","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1080\/17425255.2019.1681969","article-title":"Pharmacodynamics OF TNF \u03b1 inhibitors for the treatment of psoriasis","volume":"15","author":"Campanati","year":"2019","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.jconrel.2025.114218_bb0155","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/d41573-024-00018-2","article-title":"The pipeline and market for psoriasis drugs","volume":"23","author":"Al-Horani","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2025.114218_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052719","article-title":"The role of tumor necrosis factor alpha (TNF-\u03b1) in autoimmune disease and current TNF-\u03b1 inhibitors in therapeutics","volume":"22","author":"Jang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2025.114218_bb0165","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20240806","article-title":"Targeting TNF\/TNFR superfamilies in immune-mediated inflammatory diseases","volume":"221","author":"Veerasubramanian","year":"2024","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2025.114218_bb0170","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/imm.13843","article-title":"The role and therapeutic strategies for tissue-resident memory T cells, central memory T cells, and effector memory T cells in psoriasis","volume":"173","author":"Deng","year":"2024","journal-title":"Immunology"},{"key":"10.1016\/j.jconrel.2025.114218_bb0175","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41577-022-00792-3","article-title":"Death by TNF: a road to inflammation","volume":"23","author":"van Loo","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.114218_bb0180","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1080\/17425255.2017.1360280","article-title":"Biological anti-TNF drugs: immunogenicity underlying treatment failure and adverse events","volume":"13","author":"Prado","year":"2017","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.jconrel.2025.114218_bb0185","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1021\/acschembio.0c00313","article-title":"Tumor necrosis factor-\u03b1 trimer disassembly and inactivation via peptide-small molecule synergy","volume":"15","author":"Checco","year":"2020","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jconrel.2025.114218_bb0190","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41565-021-00898-0","article-title":"The current landscape of nucleic acid therapeutics","volume":"16","author":"Kulkarni","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2025.114218_bb0195","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nrrheum.2017.187","article-title":"Immunogenicity and loss of response to TNF inhibitors: implications for rheumatoid arthritis treatment","volume":"13","author":"Kalden","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jconrel.2025.114218_bb0200","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41573-023-00827-x","article-title":"Tailor made: the art of therapeutic mRNA design","volume":"23","author":"Metkar","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2025.114218_bb0205","first-page":"163","article-title":"Highly efficient cellular expression of circular mRNA enables prolonged protein expression, cell","volume":"31","author":"Unti","year":"2024","journal-title":"Chem. Biol."},{"key":"10.1016\/j.jconrel.2025.114218_bb0210","article-title":"A small molecule selected from a DNA-encoded library of natural products that binds to TNF-\u03b1 and attenuates inflammation in vivo","volume":"9","author":"Wang","year":"2022","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.jconrel.2025.114218_bb0215","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/s41392-024-02035-4","article-title":"Nucleic acid drugs: recent progress and future perspectives","volume":"9","author":"Sun","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2025.114218_bb0220","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12041630","article-title":"Past, present and (foreseeable) future of biological anti-TNF alpha therapy","volume":"12","author":"Leone","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jconrel.2025.114218_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114126","article-title":"A novel ionizable lipid with comprehensive improvements in transfection potency, immune profile and safety of lipid nanoparticle","author":"Guo","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114218_bb0230","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2024.2392661","article-title":"Rational optimization of glycoprotein E (gE)-encoding mRNA for improved varicella-zoster virus mRNA vaccine development","volume":"13","author":"Huang","year":"2024","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.jconrel.2025.114218_bb0235","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.ymthe.2018.03.010","article-title":"A novel amino lipid series for mRNA delivery: improved endosomal escape and sustained pharmacology and safety in non-human Primates","volume":"26","author":"Sabnis","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2025.114218_bb0240","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.1038\/s41586-024-07646-z","article-title":"Publisher correction: interim analyses of a first-in-human phase 1\/2 mRNA trial for propionic acidaemia","volume":"630","author":"Koeberl","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.114218_bb0245","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2024.2309985","article-title":"Herpes zoster mRNA vaccine induces superior vaccine immunity over licensed vaccine in mice and rhesus macaques","volume":"13","author":"Huang","year":"2024","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.jconrel.2025.114218_bb0250","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s12026-020-09149-1","article-title":"The role of Th17 cells in psoriasis","volume":"68","author":"Li","year":"2020","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jconrel.2025.114218_bb0255","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.788940","article-title":"The role of helper T cells in psoriasis","volume":"12","author":"Hu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.114218_bb0260","doi-asserted-by":"crossref","first-page":"11646","DOI":"10.1111\/jcmm.15834","article-title":"The role of Langerhans cells in epidermal homeostasis and pathogenesis of psoriasis","volume":"24","author":"Yan","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.jconrel.2025.114218_bb0265","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s12016-020-08804-7","article-title":"A review of neutrophil extracellular traps (NETs) in disease: potential anti-NETs therapeutics","volume":"61","author":"Mutua","year":"2021","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jconrel.2025.114218_bb0270","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12964-023-01381-0","article-title":"Triggers for the onset and recurrence of psoriasis: a review and update","volume":"22","author":"Liu","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.jconrel.2025.114218_bb0275","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/bjd.20963","article-title":"The biological basis of disease recurrence in psoriasis: a historical perspective and current models","volume":"186","author":"Puig","year":"2022","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jconrel.2025.114218_bb0280","article-title":"Pathophysiology of skin resident memory T cells","volume":"11","author":"Tokura","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.114218_bb0285","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jid.2016.11.033","article-title":"Dynamic changes in resident and infiltrating epidermal dendritic cells in active and resolved psoriasis","volume":"137","author":"Martini","year":"2017","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jconrel.2025.114218_bb0290","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41423-019-0291-4","article-title":"Tissue-resident memory T cells and their biological characteristics in the recurrence of inflammatory skin disorders","volume":"17","author":"Chen","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jconrel.2025.114218_bb0295","doi-asserted-by":"crossref","first-page":"10466","DOI":"10.7150\/thno.45211","article-title":"Dihydroartemisinin ameliorates psoriatic skin inflammation and its relapse by diminishing CD8(+) T-cell memory in wild-type and humanized mice","volume":"10","author":"Chen","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2025.114218_bb0300","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/ni.2744","article-title":"The developmental pathway for CD103(+)CD8+ tissue-resident memory T cells of skin","volume":"14","author":"Mackay","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2025.114218_bb0305","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1084\/jem.20130291","article-title":"Epidermal IL-15R\u03b1 acts as an endogenous antagonist of psoriasiform inflammation in mouse and man","volume":"210","author":"Bouchaud","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2025.114218_bb0310","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.immuni.2015.11.008","article-title":"T-box transcription factors combine with the cytokines TGF-\u03b2 and IL-15 to control tissue-resident memory T cell fate","volume":"43","author":"Mackay","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2025.114218_bb0315","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00011-020-01320-6","article-title":"Tissue-resident memory T cells in the skin","volume":"69","author":"Khalil","year":"2020","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.jconrel.2025.114218_bb0320","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22169004","article-title":"Tissue-resident memory T cells in skin diseases: a systematic review","volume":"22","author":"Emmanuel","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2025.114218_bb0325","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1126\/science.1690918","article-title":"Direct gene transfer into mouse muscle in vivo","volume":"247","author":"Wolff","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2025.114218_bb0330","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1126\/science.1546298","article-title":"Reversal of diabetes insipidus in Brattleboro rats: intrahypothalamic injection of vasopressin mRNA","volume":"255","author":"Jirikowski","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2025.114218_bb0335","first-page":"1397","article-title":"Characterization of a messenger RNA polynucleotide vaccine vector","volume":"55","author":"Conry","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2025.114218_bb0340","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15010166","article-title":"mRNA in the context of protein replacement therapy","volume":"15","author":"Vavilis","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.114218_bb0345","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1021\/acs.accounts.1c00550","article-title":"Lipid nanoparticle-mRNA formulations for therapeutic applications","volume":"54","author":"Wang","year":"2021","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.jconrel.2025.114218_bb0350","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16060771","article-title":"Optimizing mRNA-loaded lipid nanoparticles as a potential tool for protein-replacement therapy","volume":"16","author":"Gambaro","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.114218_bb0355","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13122090","article-title":"mRNA, a revolution in biomedicine","volume":"13","author":"Baptista","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.114218_bb0360","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41392-022-01007-w","article-title":"mRNA-based therapeutics: powerful and versatile tools to combat diseases","volume":"7","author":"Qin","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2025.114218_bb0365","series-title":"Advances in Psoriasis a Multisystemic Guide: A Multisystemic Guide","author":"Weinberg","year":"2021"},{"key":"10.1016\/j.jconrel.2025.114218_bb0370","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/bjd.19325","article-title":"Comparing the efficacy and tolerability of biologic therapies in psoriasis: an updated network meta-analysis","volume":"183","author":"Mahil","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jconrel.2025.114218_bb0375","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0140-6736(19)31773-8","article-title":"Guselkumab versus secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): results from a phase 3, randomised controlled trial","volume":"394","author":"Reich","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2025.114218_bb0380","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jaad.2022.07.002","article-title":"Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: efficacy and safety results from the 52-week, randomized, double-blinded, placebo-controlled phase 3 POETYK PSO-1 trial","volume":"88","author":"Armstrong","year":"2023","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jconrel.2025.114218_bb0385","first-page":"882","article-title":"Phototherapy: theory and practice","volume":"21","author":"Kurz","year":"2023","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"10.1016\/j.jconrel.2025.114218_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.xjidi.2022.100116","article-title":"The relapse of psoriasis: mechanisms and mysteries","volume":"2","author":"Tian","year":"2022","journal-title":"JID Innov"},{"key":"10.1016\/j.jconrel.2025.114218_bb0395","doi-asserted-by":"crossref","first-page":"46176","DOI":"10.1021\/acsami.2c11203","article-title":"Enhanced delivery of TLR7\/8 agonists by metal-organic frameworks for hepatitis B virus cure","volume":"14","author":"Wang","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2025.114218_bb0400","article-title":"Vaccination of TLR7\/8 agonist-conjugated antigen nanoparticles for Cancer immunotherapy","volume":"12","author":"Wang","year":"2023","journal-title":"Adv. Healthc. Mater."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925008302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925008302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T08:56:58Z","timestamp":1780477018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925008302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":80,"alternative-id":["S0168365925008302"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114218","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel TNF-\u03b1-targeting mRNA therapy for sustained psoriasis treatment and relapse prevention by suppressing IL-15-TRM signaling","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114218","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114218"}}